# Allison Wills

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/allison-wills/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 3 |
| i10-index | 1 |
| Last Known Institution | Celsense (United States) |
| OpenAlex ID | https://openalex.org/A5018007460 |
| Works | 12 |

## Researcher papers

- [Early access for innovative oncology medicines: a different story in each nation](https://scholariq.org/papers/early-access-for-innovative-oncology-medicines-a-different-story-in-each-nation/)
- [A Case Study of Teacher Leadership at an Elementary School](https://scholariq.org/papers/a-case-study-of-teacher-leadership-at-an-elementary-school/)
- [Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?](https://scholariq.org/papers/financial-characteristics-of-outcomes-based-agreements-what-do-canadian-public/)
- [Building infrastructure for outcomes-based agreements in Canada: can administrative health data be used to support an outcomes-based agreement in oncology?](https://scholariq.org/papers/building-infrastructure-for-outcomes-based-agreements-in-canada-can/)
- [Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective](https://scholariq.org/papers/data-collection-within-patient-support-programs-in-canada-and-implications-for/)
- [Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines](https://scholariq.org/papers/expanding-the-eligibility-criteria-for-drugs-in-canada-s-time-limited-health/)
- [Practitioner Facilitated Peer Programs in Student Mental Health: Best Practice Case Examples](https://scholariq.org/papers/practitioner-facilitated-peer-programs-in-student-mental-health-best-practice/)
- [Accelerating Oncology Drug Reimbursement in Canada: Impact of the CDA-AMC Time-Limited Recommendation and pCPA Temporary Access Process](https://scholariq.org/papers/accelerating-oncology-drug-reimbursement-in-canada-impact-of-the-cda-amc-time/)
- [RWD164 ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access](https://scholariq.org/papers/rwd164-ascot-a-case-study-in-generating-timely-and-meaningful-canadian-real/)
- [PT37 Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry](https://scholariq.org/papers/pt37-operationalizing-an-outcomes-based-marketaccess-agreement-using-real-world/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Mental Health and Patient Involvement](https://scholariq.org/topics/mental-health-and-patient-involvement/)

## Researcher university

- [Celsense (United States)](https://scholariq.org/institutions/celsense-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.